XIAP and ovarian carcinoma: Of note, Mechanistic investigations found that down-regulation of Xist might increase the expression level of X-linked inhibitor of apoptosis (XIAP) and block Taxol-induced apoptosis to cause resistance phenotype, suggesting that Xist may be a potential marker for chemotherapeutic responses in ovarian cancer [44].